G Model
MOLCAB-3462; No. of Pages9
ARTICLE IN PRESS
S. Pils et al. / Journal of Molecular Catalysis B: Enzymatic xxx (2016) xxx–xxx
5
13C NMR (100 MHz, CDCl3): 136.8, 133.7, 129.5, 128.7, 127.8, 126.6,
69.1, 23.5; MS (EI): m/z: 148 (54), 130 (47), 115 (66), 105 (100), 91
(60), 77 (45);
Table 2
Reaction mixtures.
Substrate
Enzyme concentration [M]
HPLC analysis on chiral stationary phase {Daicel Chiralcel OD-H,
n-heptane/2-propanol 90/10, 0.7 mL/min, 25 ◦C, tret(enantiomer
1) = 11.5 min, tret(enantiomer 2) = 16.8 min}: tret(major iso-
mer) = 11.5 min, ee = 94%; the physical data is in consistency with
literature [12].
Sinapyl alcohol (1c)
0.125
0.125
0.125
0.625
2.5
Coniferyl alcohol (1b)
p-Coumaryl alcohol (1a)
Cinnamyl alcohol (1d)
Piperonyl alcohol (1h)
4-Phenylbut-3-en-2-ol (1l)
Crotyl alcohol (1i)
2.5
2.5
2l: 1H NMR (300 MHz, CDCl3): 7.56-7.49 (m, 3H), 7.42-7.39 (m,
3H), 6.72 (d, J = 16.3, 1H), 2.39 (s, 3H); 13C NMR (100 MHz, CDCl3):
198.4, 143.4, 134.4, 130.5, 129.0, 128.3, 127.2, 27.6; MS (EI): m/z:
146 (60), 145 (67), 131 (71), 103 (100), 77 (50); the physical data is
in consistency with a commercial sample.
Table 3
GC-FID analytics: Retention times employing a chiral stationary phase.
Substance
Method
Retention
Retention
Retention time
time alc. 1 time alc. 2 ketone [min]
[min]
21.7
[min]
22.0
2.6. Synthesis of (Z)-3-fluoro-3-phenyl-prop-2-en-1-ol (1e)
4-Phenylbut-3-en-2-ol M7
19.3
(acetyl derivative) (1l)
2.6.1. Synthesis of ethyl (Z)-3-fluoro-3-phenylacrylate
3-Octen-2-ol (1m)
3-Penten-2-ol (1n)
Cyclohex-2-en-1-ol
(1o)
M6
M5
M6
10.2
5.4
9.8
10.5
5.6
10.2
9.0
4.1
7.6
The synthesis of ethyl (Z)-3-fluoro-3-phenylacrylate was per-
formed according to the work of Li et al. [14]. In a 5 mL round
bottom flask AgF (140 mg, 1.10 mmol, 1.9 eq.) was added to a solu-
tion of 2 mL acetonitrile and 0.1 mL H2O. Ethyl 3-phenylpropiolate
(94.5 L, 0.57 mmol, 1.0 eq.) was then added to the brownish sus-
pension and the reaction was heated to 90 ◦C for 22 h. The reaction
mixture was then cooled to room temperature and the solvents
were removed under reduced pressure. The crude product was
taken up in 10 mL H2O and washed with Et2O (3 × 10 mL). The
combined organic layers were dried over Na2SO4, filtered and con-
centrated under reduced pressure to give the crude product which
was purified via silica column chromatography with cyclohex-
ane/ethyl acetate 50:1 to 20:1 as eluent. The yield was 133 mg
(0.685 mmol, 60%)colorlessoil (Rf = 0.24, cyclohexane/ethylacetate
18:1).
4-dimethylaminopyridine (DMAP; 1 mg/mL sample) at room tem-
perature for 3 h.
Chiral GC–FID analyses of the resulting 4-phenyl-3-buten-
2-yl acetate (1l acetate) were carried out on an Agilent
7890A GC system equipped with a Restek Rt® -DEXse capillary
column (25 m × 0.32 mm × 0.25 m; stationary phase: 2,3-di-O-
ethyl-6-O-tert-butyldimethylsilyl--cyclodextrin added into 14%-
cyanopropylphenyl/86%-dimethylpolysiloxane) using hydrogen as
carrier gas.
50:1; injection volume: 1 L; column flow rate: 2 mL/min; oven
program: 60 ◦C for 1 min, 5 ◦C/min to 180 ◦C; detector temperature:
250 ◦C.
The retention times of the observed in these measurements are
summarized in Table 3.
1H NMR (300 MHz, CDCl3): ı 7.65 (d, 3JH,H = 6.7 Hz, 2H, H4 + H6),
3
7.52–7.37 (m, 3H, H1-3), 5.90 (d, JH,F = 33.3 Hz, 1H, H8), 4.26 (q,
3JH,H = 7.1 Hz, 2H, H10), 1.33 (t, 3JH,H = 7.1 Hz, 3H, H11).
13C NMR (76 MHz, CDCl3): ı 166.40 (Cq, d, JC,F = 277.6 Hz, C7),
164.18 (Cq, d, JC,F = 2.2 Hz, C9), 131.60 (CH, C1 + C3), 130.81 (Cq, d,
JC,F = 26.2 Hz, C5), 128.98 (CH, d, JC,F = 1.9 Hz, C4 + C6), 125.78 (CH,
d, JC,F = 7.9 Hz, C2), 97.35 (CH, d, JC,F = 6.9 Hz, C8), 60.55 (CH2, C10),
14.41 (CH3, C11).
2.5.2. HPLC–MS (chiral stationary phase)
HPLC analysis was performed with a Shimadzu HPLC system
using equipped with a CHIRALCEL OD-H column (Chiral Technolo-
gies Inc., West Chester, United States). Heptane/2-PrOH = 90/10
was employed as mobile phase at flow rate of 0.7 mL/min
and 25 ◦C. For the respective retention times were observed;
2.6.2. Reduction of ethyl (Z)-3-fluoro-3-phenylacrylate to
(Z)-3-fluoro-3-phenylprop-2-en-1-ol (1e)
t
ret[(R)-enantiomer] = 11.9 min,
tret[(S)-enantiomer] = 17.6 min,
In a 10 mL Schlenk-tube ethyl (Z)-3-fluoro-3-phenylacrylate
(100 mg, 0.515 mmol, 1.0 eq.) was dissolved in 3 mL CH2Cl2 and
cooled to −78 ◦C via an acetone/dry ice bath. 1.2 mL (1.192 mmol,
2.3 eq.) DIBAL-H (1.0 M in toluene) were slowly added to the col-
orless solution at −78 ◦C. The reaction mixture was then warmed
to 0 ◦C over a period of 2 h. Subsequently, the reaction was trans-
ferred into an 80 mL Schlenk-tube, diluted with CH2Cl2 (15 mL) and
quenched by the addition of H2O (1 mL). Rochelle-salt (sat.) (20 mL)
was added and the two phases were stirred vigorously for 19 h.
The aqueous phase was then washed with CH2Cl2 (3 × 20 mL) and
the combined organic layers were washed with 1 M HCl (1 × 50 mL)
and brine (1 × 50 mL), dried over Na2SO4, filtered and concentrated
under reduced pressure. The crude product was purified via column
chromatography with cyclohexane/ethyl acetate 5:1 as eluent. The
yield was 71 mg (0.466 mmol, 91%) colorless oil (Rf = 0.18, cyclo-
hexane/ethyl acetate 5:1).
and tret(ketone) = 10.5 min.
2.5.3. Scale up kinetic resolution
The substrate 1l (100 mg, 0.68 mmol) was solubilized in DMSO
(14 mL), mixed with MES buffer (50 mM, pH = 7.0, 56 mL) and incu-
bated for 3 h at 30 ◦C in a shaker at 120 rpm. The oxidase AtBBE-like
15 (350 L, 140 M) and the catalase from Micrococcus lysodeik-
ticus (1050 L, 170000 U/mL) were added and the reaction was
incubated for 20 h at 30 ◦C and 120 rpm. The reaction mixture was
extracted with diethyl ether (4 × 40 mL), the combined organic
phase was dried over with Na2SO4, filtered and concentrated in
vacuo. The crude product was purified by flash chromatography
(hexane/diethyl ether 5:1). The fractions were collected and con-
centrated in vacuo to give compounds 1l (white solid, 35 mg,
0.24 mmol, 35%) and 2l (yellow oil, 41 mg, 0.28 mmol, 41%) with
following physical properties:
1H NMR (300 MHz, CDCl3): ı 7.58–7.30 (m, 5H, H1-6), 5.66 (dt,
3JH,H,F = 36.6, 7.1 Hz, 1H, H8), 4.45 (dd, 3JH,H,F = 7.1, 1.9 Hz, 1H, H9),
1.82 (s, 1H, OH).
(R)-1l: [␣]D20 = +14.7 (c = 1.00, MeOH); lit. :[1] [␣]D20 = −17.8
[c = 0.32, MeOH, (S)-enantiomer]; 1H NMR (300 MHz, CDCl3): 7.40-
7.21 (m, 5H), 6.57 (d, J = 15.9, 1H), 6.26 (dd, J1 = 15.9, J2 = 6.4, 1H),
4.49 (dquint, J1 = 6.4, J2 = 1.0, 1H), 1.70 (bs, 1H), 1.37 (d, J = 6.4, 3H);
13C NMR (76 MHz, CDCl3): ı 158.22 (Cq, d, JC,F = 251.2 Hz, C7),
131.87 (Cq, d, JC,F = 28.6 Hz, C5), 129.44 (CH, C1 + C3), 128.66 (CH, d,
Please cite this article in press as: S. Pils, et al., Characterization of the monolignol oxidoreductase AtBBE-like protein 15 L182V for